Maria Zannes insider trades
Open-market stock purchases and sales by Maria Zannes, President & CEO at bioAffinity Technologies, Inc, from SEC Form 4 filings since Aug 31, 2022.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- BIAF bioAffinity Technologies, Inc: 1 buy, last Jan 10, 2025